Status:
UNKNOWN
Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects
Lead Sponsor:
Huashan Hospital
Collaborating Sponsors:
Wenzhou Central Hospital
Red Cross Hospital, Hangzhou, China
Conditions:
Tuberculosis, Pulmonary
Eligibility:
All Genders
18-80 years
Brief Summary
This observational Mycobacterium tuberculosis (MTB) diagnostics evaluation study is a prospective study of pulmonary TB suspects who are undergoing sputum or bronchoalveolar lavage fluid (BALF) evalua...
Eligibility Criteria
Inclusion
- Suspected pulmonary TB.
- Ability and willingness of candidate or legal guardian/representative to provide informed consent.
- Men and women age equal to or greater than 18 years.
Exclusion
- Either receipt of ≥48 cumulative hours OR three or more doses of anti-TB treatment within 180 days prior to completion of second sputum collection for Xpert testing
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2019
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04074369
Start Date
May 1 2019
End Date
October 30 2019
Last Update
August 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huashan Hospital
Shanghai, Shanghai Municipality, China, 200040